A novel approach incorporating sildenafil in the management of symptomatic neonates with Ebstein's anomaly

Pediatric Cardiology

Volumn 27, Issue 5, 2006, Pages 614-617

  Pham, Phat ^a   Hoyer, Andrew ^a   Shaughnessy, Robin ^a   Law, Yuk M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Congenital heart disease; Ebstein's anomaly; Sildenafil

Indexed keywords

PROSTAGLANDIN; SILDENAFIL;

APGAR SCORE; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYANOSIS; EBSTEIN ANOMALY; FEMALE; FETUS ELECTROCARDIOGRAPHY; GESTATIONAL AGE; HEART RIGHT VENTRICLE PRESSURE; HUMAN; INFANT; LUNG ARTERY PRESSURE; MALE; OXYGEN SATURATION; PALLIATIVE THERAPY; PATENT DUCTUS ARTERIOSUS; SIDE EFFECT; THORAX RADIOGRAPHY; TREATMENT FAILURE; WEIGHT GAIN;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; EBSTEIN'S ANOMALY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; PIPERAZINES; RADIOGRAPHY, THORACIC; SEVERITY OF ILLNESS INDEX; VASODILATOR AGENTS;

EID: 33749327519     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-006-1203-9     Document Type: Article

References (14)

1. Atz AM, Munoz RA, Adatia A, Wessel DL (2003) Diagnostic and therapeutic uses of inhaled nitric oxide in neonatal Ebstein's anomaly. Am J Caridol 91:906-908
2. Bruckheimer E, Bulbul Z, Pinter E, et al. (1998) Inhaled nitric oxide therapy in a critically ill neonate with Ebstein's anomaly. Pediatr Cardiol 19:477-479
3. Celermajer DS, Bull C, Till JA, et al. (1994) Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 23:170-176
4. Celermajer DS, Cullen S, Sullivan ID, et al. (1992) Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol 19:1041-1046
5. Chen JM, Mosca RS, Altmann K, et al. (2004) Early and medium-term results for repair of Ebstein anomaly. J Thorac Cardiovasc Surg 127:990-998
6. Danielson GK, Driscoll DJ, Mair DD, Warnes CA, Oliver WC (1992) Operative treatment of Ebstein's anomaly. J Thorac Cardiovasc Surg 104:1195-1202
7. Ghofrani HA, Pepke-Zaba J, Barbera JA, et al. (2004) Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 43:68S-72S
8. Khot UN, Novaro GM, Popovic ZB, et al. (2003) Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348:1756-1763
9. Knott-Craig CJ, Overholt ED, Ward KE, Razook JD (2000) Neonatal repair of Ebstein's anomaly: indications, surgical technique, and medium-term follow-up. Ann Throac Surg 1505-1510
10. Pflaumer A, Eicken A, Augustin N, Hess J (2004) Symptomatic neonates with Ebstein's anomaly. J Thorac Cardiovasc Surg 127:1208-1209
11. Schulze-Neick I, Hartenstein P, Li J, et al. (2003) Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 108:II167-II173
12. Ullmann MV, Born S, Sebening C, et al. (2004) Ventricularization of the atrialized chamber: a concept of Ebstein's anomaly repair. Ann Throac Surg 78:918-924
13. Wu Q, Huang Z (2004) A new procedure for Ebstein's anomaly. Ann Thorac Surg 77:470-476
14. Yetman AT, Freedom RN, McCrindle BW (1998) Outcome in cyanotic neonates with Ebstein's anomaly. Am J Cardiol 81:749-754